Clinical Trial Update: Optimizing Sysmex Technology as an Innovative Tool to Differentiate Between Malaria (PALUdism) and BACterial Infections in a Malaria Endemic Region

View source ↗

Summary

This completed clinical trial assessed using Sysmex technology to differentiate malaria from bacterial infections in a malaria-endemic region.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections
• Malaria

Snippet

Sponsor: Sysmex Europe GmbH | Conditions: Tropical Infectious Diseases | Status: COMPLETED